AI-Powered Neonatal Risk Assessment for Improved Perinatal Outcomes

Launched by FETALFIRST LIMITED · Jul 3, 2025

Keywords

ClinConnect Summary

This clinical trial is working on creating smart computer programs, called artificial intelligence (AI) models, to help doctors predict health risks and possible problems for newborn babies. By looking at past health records, including ultrasound and MRI images taken during pregnancy, these AI tools aim to give clearer information and support to families facing difficult prenatal diagnoses. The goal is to improve care for both mothers and babies before and right after birth.

The study will use existing medical records that don’t include any personal identifying information, so no new patients will be directly involved. To be included, the records must have complete information like ultrasound and MRI scans, along with clinical notes. Records that are missing important details won’t be used. This research is still in the early stages and is not yet open for recruiting participants. Ultimately, this work hopes to make prenatal care more accurate and supportive for families and healthcare providers.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Historical, de-identified neonatal records including ultrasound images, MRI scans, and clinical documentation available for analysis.
• Exclusion Criteria:
• • Cases with incomplete or missing critical data elements required for AI model analysis.